• Home
  • FLUZONE HIGH DOSE PRE-FILLED SYRINGES 10 PACK 2026

FLUZONE HIGH DOSE PRE-FILLED SYRINGES 10 PACK 2026

SKU: 49281012665
SANOFI PASTEUR, INC.
Unit Size:10
Form:PRE-FILLED SYRINGES
$698.45

Details

Details

Fluzone® High-Dose Trivalent (Influenza Vaccine) 0.5 mL Prefilled Syringe – Package of 10
2026–2027 Influenza Season

** NEEDLES NOT INCLUDED **
Age Indication: 65 years and older
Preservative Status: Preservative free
Latex Status: No latex
Antibiotic Status: No antibiotics
10 Doses
CPT Code: 90662


Storage and Handling:
** REFRIGERATED PRODUCT **
- Store refrigerated at 2-8°C (36-46°F).
- Do not freeze. Discard if the product has been frozen.
- Protect from light.

Fluzone® High-Dose Trivalent is an egg-based, inactivated split-virus influenza vaccine formulated with a higher hemagglutinin (HA) antigen content for enhanced immune response. It is supplied as a sterile, preservative-free, latex-free injectable suspension for intramuscular use.

Fluzone High-Dose is a colorless, opalescent liquid.


High-Dose Formulation Advantage

Fluzone High-Dose is manufactured using the same egg-based split-virus platform as standard Fluzone, with an additional concentration step to increase antigen content.

Key Differentiator:

  • Higher HA antigen concentration per strain compared to standard-dose influenza vaccines.

The manufacturing process includes:

  • Propagation in embryonated chicken eggs
  • Harvest of virus-containing allantoic fluid
  • Inactivation with formaldehyde
  • Purification using sucrose density gradient centrifugation
  • Chemical disruption with Triton® X-100 to produce a split-virus formulation
  • Additional concentration after ultrafiltration to increase HA antigen levels
  • Separate production of each strain before combination into final trivalent formulation

Antigen Content

Standardized according to United States Public Health Service (USPHS) requirements.

Each 0.5 mL dose contains:

  • 180 micrograms (mcg) total hemagglutinin (HA)
    • 60 mcg HA per strain
    • 4x the antigen content of standard-dose influenza vaccines (which contain 15 mcg per strain)

Manufacturing Characteristics

  • Egg-based production
  • Split-virus formulation
  • No antibiotics used in manufacturing
  • No preservatives
  • Prefilled syringe components are not made with natural rubber latex

How Supplied

  • 0.5 mL single-dose prefilled syringe (without needle)
  • Package of 10